InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,046.40
(
0.46%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
84.87
(
-0.47%
)
Bitcoin
61,292.36
(
1.71%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ilpapa

Send PM Follow Ignore
Followers 6
Posts 1313
Boards Moderated 0
Alias Born 11/02/2003

ilpapa

Re: dav1234 post# 157770

Monday, 03/04/2013 9:41:56 AM

Monday, March 04, 2013 9:41:56 AM

Post# of 252337
Patent, or patent application?

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) announced that the US Patent and Trademark Office (USPTO) has issued a key patent application covering ICT-121, an immunotherapeutic vaccine targeting CD133, an important cancer stem cell marker that is commonly overexpressed on a broad range of solid tumors.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up